Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly ...
Jewel Plummer Cobb was a cancer researcher who investigated how hormones, ultraviolet light and chemotherapeutic drugs can ...
The management of Leishmania donova ni (LD), responsible for fatal visceral leishmaniasis (VL), faces increasing challenges due to rising drug-unresponsiveness, leading to increasing treatment ...
Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...
The number of Black people living in the United States reached a new high of 48.3 million in 2023. That’s up a third (33%) since 2000, according to a Pew Research Center analysis of government data.
Kennedy Jr. will divest his interests in several biopharma companies, including CRISPR Therapeutics and Dragonfly Therapeutics, if confirmed by the ...
Research highlights modest associations between fatty acid consumption and kidney stone prevalence, emphasizing the need for refined dietary strategies. Study: Associations between dietary fatty ...
A systematic review of 573,173 individuals with type 2 diabetes found South Asian, Black, and Chinese ethnic groups have significantly lower all-cause mortality risks compared to White populations ...
This important study offers insights into the function and connectivity patterns of a relatively unknown afferent input from the endopiriform to the CA1 subfield of the ventral hippocampus, suggesting ...
Shares of CRISPR Therapeutics CRSP have lost more than 30% in the past year. Though the stock soared at the onset of 2024, thanks to the FDA approval of its one-shot gene therapy Casgevy for two ...
CRISPR Therapeutics' stock decline is likely influenced by Editas Medicine's struggles, but CRISPR remains a distinct and stronger company with a promising long-term outlook. CRISPR's strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback